Trial intelligence / Profile preview

Twinrix in Hepatitis B Vaccine Non-responders

NCT01126853Phase 4Withdrawn

Sponsor
Mount Sinai Hospital
Start
Apr 2010
Primary completion
Jun 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by Mount Sinai Hospital. Planned start Apr 2010; status: withdrawn.

02

Drugs

hepatitis b vaccine recombinant
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT01126853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01126853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call